On December 5, the report "Scaling-up the Bioregion of Catalonia" was presented, a reference study of the life sciences and health sector in Catalonia. One of the success stories highlighted in the report is a project to automate continuous bladder washes, which are being developed by professionals at the Hospital and the Vall d'Hebron Institute of Research (VHIR).On December 5, the president of the Generalitat de Catalunya, Quim Torra, and the general director of Biocat, Jordi Naval, presented the report "https://informe.biocat.cat/#home" Scaling-up the Bioregion of Catalonia". This work is an analysis of the health and life sciences sector in Catalonia, which represents 7.2% of gross domestic product (GDP), counting companies in the sector and health services. Altogether, more than 223,000 people work, around 7% of the people employed in Catalonia.The report highlights five successful cases of biotechnology transfer in the Bioregion. One of the highlighted cases is a project to automate continuous bladder washings in patients with bladder catheters. These probes are carried by urological patients' post operated with prostatic and bladder pathologies. Currently these washings are done by a manual technique. Automation would allow a substantial reduction of most complications (obstruction of the system, bladder perforation, urinary infection), as well as a reduction in costs and an increase in the quality of care. In the project, Montserrat Llinàs, Nursing Supervisor of Vall d'Hebron and Researcher of the http://en.vhir.org/portal1/grup-equip.asp?s=recerca&contentid=186757 Biomedical Research in Urology of Vall d'Hebron Research Institute (VHIR), Dr. Juan Morote, head of the Urology Service of Vall d'Hebron and head of the http://en.vhir.org/portal1/grup-equip.asp?s=recerca&contentid=186757 Biomedical Research in Urology group at VHIR, and Dr. David Lorente, of the Urology Service of Vall d'Hebron.It should be noted that one of the most important challenges of projects like this is the entry into the market and the fact that the Catalan health sector incorporates the technologies that arise from hospitals and research centers.The Biocat Report contains a series of recommendations to consolidate the strength of the sector in the coming years. The proposals include improving technology transfer incentives for researchers, encourage closer collaboration between scientists, pharmacists and investors to more specifically define proof-of-concept initiatives, strengthen local drug discovery platforms, provide specific public funding, integrate CatSalut more into the capabilities of optimizing clinical trials, improve the innovation capabilities of the Catalan health system and implement innovative public procurement programs.